New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 27, 2014
06:24 EDTSRPTSarepta downgraded to Market Perform from Outperform at JMP Securities
JMP Securities downgraded Sarepta due to valuation and expectations pivotal data and approval of its Duchenne Muscular Dystrophy drug will take longer than expected.
News For SRPT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 6, 2015
08:53 EDTSRPTSarepta risk/reward attractive, says Roth Capital
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use